Clinical Trials Logo

Breast Neoplasms clinical trials

View clinical trials related to Breast Neoplasms.

Filter by:

NCT ID: NCT04875351 Active, not recruiting - Breast Cancer Clinical Trials

Breast Cancer Index (BCI) Registry

Start date: April 14, 2021
Phase:
Study type: Observational [Patient Registry]

The purpose of the Breast Cancer Index (BCI) Registry study is to conduct a large scale, population-based prospective registry to evaluate long-term clinical outcome, clinical impact, medication adherence and quality of life in hormone receptor positive (HR+) early-stage breast cancer patients receiving BCI testing as part of routine clinical care to inform extended endocrine therapy.

NCT ID: NCT04872738 Active, not recruiting - Covid19 Clinical Trials

Patient Experiences With the COVID-19 Vaccination After Breast Cancer Treatment

LymphVAX
Start date: May 7, 2021
Phase:
Study type: Observational

This study aims to elicit patient experiences, choices, and side effects associated with the COVID-19 vaccine after breast cancer surgery. Lymph node swelling is a known and common side effect of both the Moderna and Pfizer COVID-19 vaccines. This is the body's normal reaction to the vaccine. It is worrisome that lymph node swelling after the vaccine mimics that found in breast cancer which has spread to the lymph nodes. This side effect will cause worry and anxiety amongst patients as a result. For patients who have had lymph node removal (axillary lymph node dissection or sentinel lymph node biopsy) and are at risk of lymphedema, the investigators are concerned that the lymph node swelling may tax the lymphatic system and incite lymphedema in those at risk or worsen it in those with BCRL. Fear of lymphedema is high in this population and the investigators need to better understand what risk, if any, lymph node swelling after the COVID-19 vaccine imparts to BCRL risk.

NCT ID: NCT04855552 Active, not recruiting - Clinical trials for Overweight and Obesity

Telehealth Weight Loss Program for Breast Cancer Survivors

TWL
Start date: July 19, 2021
Phase: N/A
Study type: Interventional

This is a single-arm longitudinal group to examine patient-reported outcomes, body mass and mammographic density changes pre- and post- weight loss intervention of breast cancer survivors using video conferencing telehealth visits.

NCT ID: NCT04835597 Active, not recruiting - Clinical trials for Anatomic Stage III Breast Cancer AJCC v8

Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Start date: August 15, 2022
Phase:
Study type: Observational

This study assesses the performance status in stage I-III triple negative breast cancer patients who are receiving neoadjuvant chemotherapy. Information collected in this study may help doctors learn if movement and fitness trackers can be used to predict side effects in cancer patients receiving chemotherapy.

NCT ID: NCT04834154 Active, not recruiting - Breast Cancer Clinical Trials

Mental Health Disparities in Spanish Speaking Latina Breast Cancer Patients

Start date: March 15, 2021
Phase: N/A
Study type: Interventional

The purpose of the study is to:Translate a mindfulness program into Spanish for Latina patients with breast cancer.Train a community health worker to facilitate the mindfulness program. Determine if this program is culturally acceptable and feasible, and Obtain pilot data on the program's effectiveness in reducing anxiety and depression

NCT ID: NCT04832594 Active, not recruiting - Breast Cancer Clinical Trials

Using AI to Select Women for Supplemental MRI in Breast Cancer Screening

ScreenTrustMRI
Start date: April 1, 2021
Phase: N/A
Study type: Interventional

This is a prospective clinical trial aiming to determine the ability of an AI pipeline to identify women who would benefit from supplemental MRI in terms of decreasing the number of cancers having a significantly delayed detection

NCT ID: NCT04821375 Active, not recruiting - Clinical trials for Increased Risk for Development of Breast Cancer

Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers

Start date: December 2, 2021
Phase: Early Phase 1
Study type: Interventional

Pilot study to test feasibility of 6 months of bazedoxifene (BZA) plus conjugated estrogens (CE) to modulate breast MRI parameters.

NCT ID: NCT04818359 Active, not recruiting - Clinical trials for Breast Cancer Survivors

Movement and Health Beyond Care (MoviS)

MoviS
Start date: January 7, 2020
Phase: N/A
Study type: Interventional

MoviS is a randomized controlled trial on the effect of aerobic exercise training on quality of life (QoL) among breast cancer (BC) survivors. Patients randomized to the intervention arm will receive lifestyle recommendations (nutrition and exercise) and will undergo the MoviS Training program, whereas control arm patients will receive lifestyle recommendations. The MoviS Training program consists of 3 months, 3 times per week, aerobic exercise, which will be supervised both directly (2 days each week) and remotely (1 day each week). Exercise intensity (40% to 70% of heart rate reserve) and duration (20 to 60 mins) will be gradually increased throughout the training period. Both arms will receive counseling on psychological well-being. The primary outcome is the improvement of QoL. The secondary outcome is the improvement of the health-related parameters. Study variables will be sampled and compared between and within groups at the baseline, after the 3 month intervention period, ad interim in the short term (6 months) and long term (12 and 24 months).

NCT ID: NCT04812652 Active, not recruiting - Clinical trials for Breast Neoplasm Female

Digitally Distributed Yoga for Women Treated for Breast Cancer

DigiyogaCare
Start date: October 1, 2021
Phase: N/A
Study type: Interventional

Breast cancer is the most common cancer disease in women. As the prevalence of fatigue is high in this group it is motivated to find interventions that can reduce fatigue and render in an increased level of physical activity both during and after treatment. Yoga have shown effect on cancer related fatigue (CRF) and is a rehabilitation activity that is often requested by breast cancer patients. Breast cancer patients live in cites and small-towns as well as in rural areas and therefore there is a need for accessible rehabilitation activities for all patients despite place of residence. A digitally distributed yoga class can potentially increase accessibility for those living in rural areas. Aim The overarching aim of this study is to investigate the effect of a 12-weeks digitally distributed yoga intervention for women treated for breastcancer, compared with a control group receiving regular care, concerning: - patient reported outcomes, primary endpoint CRF - systemic inflammation - activity level The study will evaluate if there are differences during and after the intervention and if those differences are sustained after 1, 3, 6, 12 and 24 months after the intervention. Additional objectives are to compare the two groups concerning completing oncologic treatment, cost effectiveness, return to work and also to describe the patients experiences of participating in a digitally distributed yoga class at home. Research questions If and how a digitally distributed yoga can influence cancer related fatigue, stress, health related quality of life and level of physical activity compared to regular care? If and how a digitally distributed yoga can have an effect on systemic inflammation? How is the feasibility of digitally distributed yoga twice weekly at home? What is the breast cancer patients' experience of participating in digitally distributed yoga clas?

NCT ID: NCT04803266 Active, not recruiting - Breast Neoplasms Clinical Trials

Elective Internal Mammary Node Irradiation in Women With Node-positive Breast Cancer

Start date: November 5, 2008
Phase: Phase 3
Study type: Interventional

The aim of this study is to find out whether the inclusion of internal mammary node irradiation in regional nodal irradiation improves outcomes in women with node-positive breast cancer.